Similar articles for PMID: 25941261

Year	Number of Results
1966	1
1983	1
1987	3
1992	3
1993	1
1994	2
1995	3
1997	2
1999	3
2000	1
2002	1
2005	3
2006	5
2007	2
2008	2
2009	1
2010	4
2011	6
2012	6
2013	10
2014	8
2015	15
2016	17
2017	11
2018	15
2019	9
2020	5
2021	2
2022	5
2024	0

1

Can reporting of adverse drug reactions create safer systems while improving health data?

Hohl C, Lexchin JR, Balka E. Hohl C, et al. CMAJ. 2015 Aug 11;187(11):789-790. doi: 10.1503/cmaj.150057. Epub 2015 May 4. CMAJ. 2015. PMID: 25941261 Free PMC article. No abstract available.

2

Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.

Liu F, Jagannatha A, Yu H. Liu F, et al. Drug Saf. 2019 Jan;42(1):95-97. doi: 10.1007/s40264-018-0766-8. Drug Saf. 2019. PMID: 30649734 Free PMC article. No abstract available.

3

Report of Adverse Events in Colombia: A Successful Case.

Moreno-Mattar O, Ramírez R, Alvarado A, Sierra F, Guzmán J. Moreno-Mattar O, et al. Curr Drug Saf. 2019;14(1):53-56. doi: 10.2174/1574886313666181109150648. Curr Drug Saf. 2019. PMID: 30411692

4

Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Camacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins Rde M, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS; Brighton Collaboration Viscerotropic Disease Working Group. Gershman MD, et al. Vaccine. 2012 Jul 13;30(33):5038-58. doi: 10.1016/j.vaccine.2012.04.067. Epub 2012 May 4. Vaccine. 2012. PMID: 22561144 Free PMC article. No abstract available.

5

Re: adverse drug reactions in older patients during hospitalisation: are they predictable?

Griebling T. Griebling T. J Urol. 2013 Aug;190(2):623. doi: 10.1016/j.juro.2013.04.124. Epub 2013 May 7. J Urol. 2013. PMID: 23845357 No abstract available.

6

Effect of reporting bias in the analysis of spontaneous reporting data.

Ghosh P, Dewanji A. Ghosh P, et al. Pharm Stat. 2015 Jan-Feb;14(1):20-5. doi: 10.1002/pst.1657. Epub 2014 Nov 6. Pharm Stat. 2015. PMID: 25376637

7

How to Investigate a Serious Adverse Event Reported During a Clinical Trial for a COVID-19 Vaccine.

Shakir S, Lane S, Davies M. Shakir S, et al. Drug Saf. 2021 Jan;44(1):1-5. doi: 10.1007/s40264-020-01018-y. Epub 2020 Nov 21. Drug Saf. 2021. PMID: 33219926 Free PMC article. No abstract available.

8

Detecting Adverse Drug Events: Accuracy and Generalizability.

Walter SR, Gallego B. Walter SR, et al. Ther Innov Regul Sci. 2019 Nov;53(6):795-796. doi: 10.1177/2168479018820045. Epub 2018 Dec 30. Ther Innov Regul Sci. 2019. PMID: 30595045

9

Minimising harm: human variation and adverse drug reactions (ADRs).

Ritter JM. Ritter JM. Br J Clin Pharmacol. 2008 Apr;65(4):451-2. doi: 10.1111/j.1365-2125.2008.03170.x. Br J Clin Pharmacol. 2008. PMID: 18333858 Free PMC article. No abstract available.

10

The class imbalance problem detecting adverse drug reactions in electronic health records.

Santiso S, Casillas A, Pérez A. Santiso S, et al. Health Informatics J. 2019 Dec;25(4):1768-1778. doi: 10.1177/1460458218799470. Epub 2018 Sep 19. Health Informatics J. 2019. PMID: 30230408 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

136 results

Results by year